Partners
Cooperating partners
ResearchGate
Cooperating conferences
AMMF's Hybrid 2024 European Cholangiocarcinoma Conference
Time and Venue: 8-10 May 2024 | Live at the Radisson Blu Hotel, London Stansted Airport, Essex, UK, and virtual.
About: For 2024, AMMF is delighted to welcome Professor Shahid Khan and Professor Chiara Braconi, two internationally renowned specialists at the forefront of the CCA world, who will co-chair a conference dedicated to exploring the advances that are happening now. They will host a faculty of speakers selected from across the globe who will speak of the challenges faced and advances made in the understanding of CCA, and will discuss the importance of accelerating the progress we are now seeing.
AMMF welcomes the whole CCA community, from health care professionals and researchers to patients, and invites everyone to unite, network and learn together!
Submit an abstract before 15 March for a chance to display your work in a poster exhibition.
The 7th Global MASLD Congress
Time and Venue: 24-25 June 2024 | The London Heathrow Marriot Hotel
About: MASH/MASLD incidence rates are continuing to rise globally year after year as the disease continues to be a global health concern. Although no pharmaceutical drugs have yet received regulatory approval, there are a number of therapeutics in late-phase clinical trials, case studies of which will be discussed at the congress, as well as pre-clinical developments. Potential alternatives for MASH diagnosis in the form of non-invasive biomarkers will be explored to replace the invasive liver biopsy. Advances in the research of MASH disease mechanisms such as genetic predisposition, gut microbiome, and mitochondrial dysfunction will be covered as the disease pathology continues to be complex and not fully understood.
The Inaugural Combined GIHep & Singapore Hepatology Conference
Time and Venue: 1-3 June 2023 | Singapore
About: Coming soon.
Website: https://shc-sg.com/
AMMF's Hybrid 2023 European Cholangiocarcinoma Conference
Time and Venue: 10–12 May 2023 | Live at the Radisson Blu Hotel, Stansted Airport, Essex, UK.
About: AMMF's 2023 cholangiocarcinoma (CCA) conference will unite an expert faculty to deliver an engaging hybrid event exploring the European and international aspects of CCA. The 'live' event will be held at the Radisson Blu Hotel Stansted, UK, and the sessions will be broadcast in real-time to the online audience.
This year, AMMF is delighted to welcome Professor John Bridgewater and Professor Lorenza Rimassa, two internationally renowned specialists at the forefront of the CCA world, who will co-chair a conference dedicated to exploring “Innovation”. They will host a faculty of speakers, selected from across the globe, who will speak of the challenges faced and advances made in the understanding of CCA, and will discuss the importance of the accelerating progress we are now seeing.
This year, AMMF is delighted to welcome Professor John Bridgewater and Professor Lorenza Rimassa, two internationally renowned specialists at the forefront of the CCA world, who will co-chair a conference dedicated to exploring “Innovation”. They will host a faculty of speakers, selected from across the globe, who will speak of the challenges faced and advances made in the understanding of CCA, and will discuss the importance of the accelerating progress we are now seeing.
17th ILCA Annual Conference
Time and Venue: 7-9 September 2023 | Amsterdam, The Netherlands
About: ILCA Annual Conference is the ultimate gathering of liver cancer experts. Taking place from 7-9 September 2023, in Amsterdam, this conference is the perfect opportunity to hear from the world's leading experts, network with your peers, and stay up to date on the latest advancements in liver cancer treatment and care. Don't miss out on this unique chance to advance your knowledge and take your career to the next level.
18th Congress of the Middle East Society for Organ Transplantation (MESOT)
Time and Venue: 24-26 May 2023 - Ankara - Turkey
About: It is a great honor and privilege to announce the 18th Congress of the Middle East Society for Organ Transplantation (MESOT) to be held on May 24-26, 2023 in Ankara, Turkey. The Congress will be endorsed by The Transplantation Society (TTS), The Turkish Transplantation Society (TOND) and The Turkic World Transplantation Society (TDTD).
Transplantation activities in MESOT countries are growing daily and the quality of the medical and surgical treatment provided for the patients is on par with the most developed countries in the world.
The 18th Congress of the MESOT will be an ideal opportunity to share and learn from each other. State-of-the-art lectures, plenaries, oral presentations and poster receptions will stimulate deep discussions on the latest scientific research in all fields of organ transplantation in the Middle East, Mid Asia and the world.
We are currently planning on a live meeting. However, depending on the circumstances, it may become a hybrid meeting and we will keep you updated regularly through MESOT 2023 website.
The scientific, cultural, and historical elements Ankara as the host city would offer participants from all over the world an unforgettable experience. We warmly invite you all to come and enjoy our Turkish hospitality, and we look forward to welcoming you to Ankara in May 2023.
Transplantation activities in MESOT countries are growing daily and the quality of the medical and surgical treatment provided for the patients is on par with the most developed countries in the world.
The 18th Congress of the MESOT will be an ideal opportunity to share and learn from each other. State-of-the-art lectures, plenaries, oral presentations and poster receptions will stimulate deep discussions on the latest scientific research in all fields of organ transplantation in the Middle East, Mid Asia and the world.
We are currently planning on a live meeting. However, depending on the circumstances, it may become a hybrid meeting and we will keep you updated regularly through MESOT 2023 website.
The scientific, cultural, and historical elements Ankara as the host city would offer participants from all over the world an unforgettable experience. We warmly invite you all to come and enjoy our Turkish hospitality, and we look forward to welcoming you to Ankara in May 2023.
MAIDEN
About: MAIDEN, the METABOLIC FATTY LIVER DISEASE CONSORTIUM, founded in 2022, is a medical association dedicated to pursuing excellence in liver research, to the clinical practice of fatty liver disease, and to providing education to all those interested in MAFLD and to be the official body to represent APASL on any matters related to fatty liver disease.
Website: https://maiden-apasl.com/
Previous conferences
16th ILCA Annual Conference
Time and Venue: 1-4 September 2022 - Madrid, Spain.
About: The International Liver Association (ILCA) is proud to present the 16th edition of its Annual Conference, which will take place in Madrid, Spain, on 1-4 September 2022. We will gather in the historic capital of Spain for four days of knowledge sharing, scientific learning, and intensive networking.
At ILCA AC2022, you can expect a meeting of minds, practical insights, workshops, big idea presentations, and, of course, exciting debate formats to encourage the sharing of the latest insights and learnings for the greatest impact between physicians, researchers, and partners from all over the world.
At ILCA AC2022, you can expect a meeting of minds, practical insights, workshops, big idea presentations, and, of course, exciting debate formats to encourage the sharing of the latest insights and learnings for the greatest impact between physicians, researchers, and partners from all over the world.
APPLE 2022 12th Asia-Pacific Primary Liver Cancer Expert meeting
Time and Venue: 12-14 August 2022 - Shanghai, China.
About: The 12th Asia-Pacific Primary Liver Cancer Expert Meeting (2022 APPLE), hosted by the APPLE Committee, supported by the China Primary Health Care Foundation, and organized by the Oncology Branch of the Chinese Medical Association, the Surgeon Branch of the Chinese Medical Doctor Association, the Liver Cancer Professional Committee of the Chinese Anti-Cancer Association, and Zhongshan Hospital,Fudan University, will be arranged as a virtual or hybrid meeting entitled“New perspectives in the era of targeted and immunological therapies for liver cancer”, which to be held in Shanghai, China, on the 12-14 August 2022.
Established in 2013, the APPLE Association is a worldwide leading academic organization for primary liver cancer. Targeting mainly at facilitating the scientific management of liver cancer diagnosis and treatment, exchanging information and reaching consensus in the field of liver cancer, it expects to advance the basic education and clinical diagnosis and treatment of liver cancer by means of academic exchanges such as clinical and scientific research of liver cancer.
International well-known experts and domestic experts in the field of liver cancer will be invited to this meeting to have discussions on the molecular pathogenesis and pathology of HCC, surgery and liver transplantation for HCC, locoregional therapy for HCC: new roles in immunotherapy era, systemic therapy for earlier-stages of HCC, cholangiocarcinoma, systemic therapy for advanced HCC etc., so as to jointly explore new strategies for the treatment of liver cancer. We look forward to meeting you at the meeting in August in Shanghai to seek common development and look into the future.
Established in 2013, the APPLE Association is a worldwide leading academic organization for primary liver cancer. Targeting mainly at facilitating the scientific management of liver cancer diagnosis and treatment, exchanging information and reaching consensus in the field of liver cancer, it expects to advance the basic education and clinical diagnosis and treatment of liver cancer by means of academic exchanges such as clinical and scientific research of liver cancer.
International well-known experts and domestic experts in the field of liver cancer will be invited to this meeting to have discussions on the molecular pathogenesis and pathology of HCC, surgery and liver transplantation for HCC, locoregional therapy for HCC: new roles in immunotherapy era, systemic therapy for earlier-stages of HCC, cholangiocarcinoma, systemic therapy for advanced HCC etc., so as to jointly explore new strategies for the treatment of liver cancer. We look forward to meeting you at the meeting in August in Shanghai to seek common development and look into the future.
2020 Chinese Academic Conference on Tumor Biomarker (CCTB)
Time and Venue: 11th - 13th December 2020, Guangzhou City, Guangdong Province, China
About: The conference will be held in Guangzhou, China, December 11-13th, 2020, which is sponsored by the Committee of Tumor Biomarker and Holistic Integrative Oncology Branch, Chinese Anti-Cancer Association, and hosted by The Sixth Affiliated Hospital, Sun Yat-sen University.
The theme of the conference is "innovation, transformation, cooperation and sharing". The conference will also invite many prominent scientists from China and overseas. There will be many informative lectures on current progress of cancer research and basic translating research, as well as clinical and industrial applications.
The theme of the conference is "innovation, transformation, cooperation and sharing". The conference will also invite many prominent scientists from China and overseas. There will be many informative lectures on current progress of cancer research and basic translating research, as well as clinical and industrial applications.
ILCA 2019 − The International Liver Cancer Association’s 13th Annual Conference
Time and Venue: 20−22 September 2019, Chicago, USA
About: The International Liver Cancer Association (ILCA) is pleased to bring its 13th Annual Conference to the beautiful city of Chicago, USA, offering a programme with a multidisciplinary and transversal approach, with the objective to encourage and stimulate scientific debate and networking between liver cancer experts from all regions.
Clinical, translational and basic researchers, physicians and allied professionals across liver cancer related disciplines will convene at ILCA 2019 to share best practices and findings, making this event the premier forum for advancing research in the pathogenesis, prevention, and treatment of liver cancer.
The conference will feature sessions on the following topics:
• The Cell of Origin of Liver Cancer
• The Patient Perspective on Cancer Treatment
• Clinical Trials
• Peri Hilar Cholangiocarcinoma
• Molecular Diversity in HCC
• Systemic Therapy
• Surgery for Primary Liver Cancer
• Imaging of HCC Response to Loco-Regional and Systemic Therapy
• Molecular Lessons Learnt from Clinical Trials in the Last Decade
• Treatment and Response
The deadline to submit your abstract is 8 April 2019 and the deadline to benefit from early registration discounts is 1 July 2019.
Clinical, translational and basic researchers, physicians and allied professionals across liver cancer related disciplines will convene at ILCA 2019 to share best practices and findings, making this event the premier forum for advancing research in the pathogenesis, prevention, and treatment of liver cancer.
The conference will feature sessions on the following topics:
• The Cell of Origin of Liver Cancer
• The Patient Perspective on Cancer Treatment
• Clinical Trials
• Peri Hilar Cholangiocarcinoma
• Molecular Diversity in HCC
• Systemic Therapy
• Surgery for Primary Liver Cancer
• Imaging of HCC Response to Loco-Regional and Systemic Therapy
• Molecular Lessons Learnt from Clinical Trials in the Last Decade
• Treatment and Response
The deadline to submit your abstract is 8 April 2019 and the deadline to benefit from early registration discounts is 1 July 2019.
Website: https://ilca-online.org/2019/
2019 Chinese Academic Conference on Tumor Biomarker (CCTB) & the 13th Youth Scientists Forum on Tumor Biomarker
Time and Venue: 6th - 8th December 2019, Wuhan City, Hubei Province, China
About: 2019 Chinese Academic Conference on Tumor Biomarker (CCTB) & the 13th Youth Scientists Forum on Tumor Biomarker will be held during December 6-8, 2019 in Wuhan City, Hubei Province, China. We look forward to seeing you there!
14th Annual Conference of the International Liver Cancer Association (ILCA)
Time and Venue: 11−13 September 2020
About: The ILCA 2020 will be a fully Virtual Conference which will take place between 11-13 September and will feature a three-day programme focusing on regulatory facts and trends, practical information, and the latest developments regarding the liver cancer field. Save the date and learn more about the conference at The ILCA 2020 will be a fully Virtual Conference which will take place between 11-13 September and will feature a three-day programme focusing on regulatory facts and trends, practical information, and the latest developments regarding the liver cancer field.
AMMF
Time and Venue: 11–13 May 2022 | Live at the Radisson Blu Hotel, Stansted Airport, Essex, UK.
About: AMMF’s 2022 cholangiocarcinoma (CCA) conference will mark 20 years since the inception of AMMF by bringing together an expert faculty and speakers to deliver an engaging hybrid event which will explore the European and international aspects of CCA and allow delegates to join the meeting 'live' or online. The 'live' event will be held at the Radisson Blu Hotel Stansted, UK, and the sessions will be broadcast in real-time to the online audience.
This anniversary year, AMMF is delighted to welcome Professor Juan Valle and Professor Jesus Bañales, two internationally renowned specialists at the forefront of the CCA world, who will co-chair the conference. They will host a faculty of speakers selected from across the globe who will speak of the challenges faced and advances made in the understanding of CCA over the past two decades, and will discuss the importance of the accelerating progress we are now seeing.
This anniversary year, AMMF is delighted to welcome Professor Juan Valle and Professor Jesus Bañales, two internationally renowned specialists at the forefront of the CCA world, who will co-chair the conference. They will host a faculty of speakers selected from across the globe who will speak of the challenges faced and advances made in the understanding of CCA over the past two decades, and will discuss the importance of the accelerating progress we are now seeing.
3rd International Conference on Fatty Liver (ICFL 2022)
Time and Venue: 28-30 April 2022 - Vienna, Austria.
About: It is our pleasure to invite you to the 3rd International Conference on Fatty Liver (ICFL 2022) taking place 28-30 April 2022 in Vienna, Austria.
The only event inviting clinicians, researchers, and healthcare professionals in the field of hepatology, gastroenterology, diabetology, nutrition, radiology, and cardiology to address the issue of fatty liver disease and the relationship with the body.
ICFL 2022 will focus on the clinical needs and best practices for diagnosing and treating Fatty Liver. Together we can raise awareness across all specialties to help guide and treat our patients, increase our knowledge on the early warning signs and provide access to a wider spectrum of data/research from a multidisciplinary point of view.
The only event inviting clinicians, researchers, and healthcare professionals in the field of hepatology, gastroenterology, diabetology, nutrition, radiology, and cardiology to address the issue of fatty liver disease and the relationship with the body.
ICFL 2022 will focus on the clinical needs and best practices for diagnosing and treating Fatty Liver. Together we can raise awareness across all specialties to help guide and treat our patients, increase our knowledge on the early warning signs and provide access to a wider spectrum of data/research from a multidisciplinary point of view.
Website: https://icfl.kenes.com/
The Science of HBV Cure Meeting 2022
Time and Venue: 30 May to 2nd June 2022 | Online
About: The Singapore Hepatology Conference Organising Committee invites you to attend our sister conference. REGISTRATION FOR SHC 2022 will enable you to attend HBV Cure 2022 and vice versa. Thanks to the generous support of our Sponsors, No registration fee is required. HBV Cure 2022 will feature an extensive line up of World Renowned Experts from Academic AND Industry in the Science of Hepatitis B Cure. They will share and provide a comprehensive update on their research works.
Website: https://shc-sg.com/
Singapore Hepatology Conference (SHC 2022)
Time and Venue: 30 May to 2 June 2022 | Online
About: More than 24 months after the start of the Covid pandemic and widespread, effective vaccinations, we are still unable to travel freely between countries. So, the SHC organisers have decided to do the next best thing – hold a Hybrid Conference using state-of-the-art technology to give all Clinicians and Scientists an experience as close to a LIVE conference as possible. Each evening Monday to Thursday, 30 May to 2 June 2022, from 6.00 pm to 10.30 pm SGT, SHC2022 Hybrid Conference will focus on delivering short sharp updates on the developments in the treatment and management of patients with Liver Diseases. Our sister conference, The Science of HBV Cure Meeting 2022, will also be hybrid and held on the same dates but from 2.00 pm to 5.00 pm SGT. We look forward to seeing you, online at SHC 2022, Hybrid Conference and our sister conference, the Science of HBV Cure 2022.
Website: https://shc-sg.com/
